Roivant Sciences continues its partnership with BaseLaunch for phase II
24 June 2020 We welcome back Roivant Sciences with open arms for … Continue reading “Roivant Sciences continues its partnership with BaseLaunch for phase II”
24 June 2020 We welcome back Roivant Sciences with open arms for … Continue reading “Roivant Sciences continues its partnership with BaseLaunch for phase II”
23 June 2020, Cambridge, UK: STORM Therapeutics, the leading biotechnology company focused … Continue reading “STORM Therapeutics appoints Dr. Josefin-Beate Holz as Chief Medical Officer”
Our CEO Gerben Moolhuizen will present on Thursday, June 25 3:40pm at … Continue reading “ISA Pharmaceuticals to present at the Virtual European Biotech Investor Day 2020”
Leiden, The Netherlands, June 17, 2020, — ISA Pharmaceuticals B.V., a private … Continue reading “ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron”
Breakthrough approach to developing first-in-class treatments for metastatic cancer patients Financing to … Continue reading “Ona Therapeutics raises €30M in Series A financing”
Fund+ Announces Investment in Ona Therapeutics – EUR30 Million Series A financing … Continue reading “Fund+ Announces Investment in Ona Therapeutics”
Belgium, 15 June 2020: Fund+, an investment firm focused on innovative European Life … Continue reading “Fund+ Appoints Luc Debruyne and Gérard Lamarche to the Board of Directors”
Today, the Novo Holdings REPAIR Impact Fund announced it has opened a … Continue reading “The REPAIR Impact Fund launches global call for new investment proposals to fight AMR”
Novo Ventures, part of Novo Holdings, today announced that it has led … Continue reading “Novo Ventures Leads US$ 55M Series B Investment in NodThera”
Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a … Continue reading “Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75”
Geneva, Switzerland, 27 May 2010: iOnctura SA, a clinical stage biopharmaceutical company, developing … Continue reading “iOnctura Appoints Industry Veteran Dr. Joanna Horobin as Chair”
BaseLaunch, the Basel Area-based incubator and accelerator that helps scientists and entrepreneurs … Continue reading “Roche becomes founding partner of BaseLaunch Phase II”
Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation … Continue reading “Acesion Pharma Strengthens Clinical Team with Key Appointments”
First calcium matrix to receive European approval as an antibiotic carrier for … Continue reading “Biocomposites announces new CE Mark for STIMULAN®”
Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman Basel, Switzerland, 22 … Continue reading “FoRx Therapeutics AG Raises EUR 10 Million Seed Round First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer”
20 April 2020, Cambridge, UK: STORM Therapeutics, the biotechnology company focused on … Continue reading “STORM Therapeutics appoints Dr. Angus Lauder as Director of Business Development”
17 April 2020, Cambridge, UK: STORM Therapeutics, the biotechnology company focused on … Continue reading “STORM Therapeutics announces publication in Nature Reviews Cancer on the role of RNA Modifications in Cancer by Founder Professor Tony Kouzarides”
LONDON, 15 April 2020: Arix Bioscience plc (LSE: ARIX) (“Arix” or the … Continue reading “Jonathan Tobin, PhD, promoted to Managing Director, Arix Bioscience”
Targeting reconstruction, spine, trauma and foot and ankle Keele, UK, 15 April … Continue reading “Biocomposites Appoints President”
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2020 Optimum Strategic Communications All rights reserved.
Warnford Court
29 Throgmorton Street
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com